Anti-Human MCP-1/CCL2 Rabbit Recombinant Antibody

MCP-1/CCL2 Uni-rAbTM Recombinant Antibody for FC (Intra)
Cat No. 98044-1-RR
Clone No.230270A7

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

FC (Intra)

CCL2, MCP1, MCP-1, CCL-2, CCL 2

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive FC (Intra) detected inPMA, LPS and Brefeldin A treated THP-1 cells

Recommended dilution

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

98044-1-RR targets MCP-1/CCL2 in FC (Intra) applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen Fusion Protein Predict reactive species
Full Name chemokine (C-C motif) ligand 2
Calculated Molecular Weight 99 aa, 11 kDa
GenBank Accession NumberBC009716
Gene Symbol MCP-1/CCL2
Gene ID (NCBI) 6347
RRIDAB_3672191
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purfication
UNIPROT IDP13500
Storage Buffer PBS with 0.09% sodium azide.
Storage ConditionsStore at 2-8°C. Stable for one year after shipment.

Background Information

Monocyte chemotactic protein 1 (MCP-1; also known as CCL2), is chemotactic for monocyte/macrophage, B-cell, and T-lymphocyte, and belongs to the CC subfamily of chemokines. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The human ortholog has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, such as psoriasis, rheumatoid arthritis, and atherosclerosis.

Protocols

Product Specific Protocols
FC protocol for MCP-1/CCL2 antibody 98044-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...